Sterling Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Buy |
16,745
+12,221
| +270% | +$1.31M | 0.03% | 423 |
|
|
2025
Q1 | $456K | Buy |
4,524
+52
| +1% | +$5.25K | 0.01% | 882 |
|
|
2024
Q4 | $399K | Sell |
4,472
-2,253
| -34% | -$201K | 0.01% | 1045 |
|
|
2024
Q3 | $564K | Buy |
+6,725
| New | +$564K | 0.01% | 798 |
|
|
2018
Q4 | – | Sell |
-254,374
| Closed | -$9.79M | – | 849 |
|
|
2018
Q3 | $9.79M | Hold |
254,374
| – | – | 0.09% | 195 |
|
|
2018
Q2 | $8.32M | Sell |
254,374
-19,847
| -7% | -$649K | 0.08% | 202 |
|
|
2018
Q1 | $7.49M | Hold |
274,221
| – | – | 0.07% | 216 |
|
|
2017
Q4 | $6.8M | Sell |
274,221
-32,428
| -11% | -$804K | 0.06% | 222 |
|
|
2017
Q3 | $8.95M | Hold |
306,649
| – | – | 0.08% | 194 |
|
|
2017
Q2 | $8.5M | Sell |
306,649
-96,416
| -24% | -$2.67M | 0.08% | 195 |
|
|
2017
Q1 | $10M | Buy |
403,065
+6,252
| +2% | +$155K | 0.09% | 182 |
|
|
2016
Q4 | $8.58M | Sell |
396,813
-21,699
| -5% | -$469K | 0.08% | 188 |
|
|
2016
Q3 | $9.96M | Sell |
418,512
-3,000
| -0.7% | -$71.4K | 0.09% | 171 |
|
|
2016
Q2 | $9.85M | Buy |
421,512
+543
| +0.1% | +$12.7K | 0.09% | 168 |
|
|
2016
Q1 | $7.92M | Buy |
420,969
+135,303
| +47% | +$2.54M | 0.07% | 190 |
|
|
2015
Q4 | $5.27M | Buy |
285,666
+101,092
| +55% | +$1.86M | 0.05% | 245 |
|
|
2015
Q3 | $3.03M | Buy |
184,574
+90,484
| +96% | +$1.48M | 0.03% | 295 |
|
|
2015
Q2 | $1.67M | Buy |
94,090
+44,090
| +88% | +$780K | 0.02% | 331 |
|
|
2015
Q1 | $887K | Buy |
+50,000
| New | +$887K | 0.01% | 479 |
|